Voyageur Pharmaceuticals Ltd. VYYRF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.94% | 26.39% | 34.79% | -145.72% | 32.24% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,984.23% | 131.18% | -148.38% | -14.99% | -28.26% |
| Change in Net Operating Assets | 54.29% | -29.26% | 225.54% | 372.67% | 88.52% |
| Cash from Operations | 345.42% | 54.64% | 58.84% | -175.76% | 67.52% |
| Capital Expenditure | -48.69% | 71.02% | 21.45% | -474.66% | 50.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -48.69% | 71.02% | 21.45% | -474.66% | 50.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.22% | 1,709.09% | -94.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -230.28% | -3,335.00% | 96.97% |
| Cash from Financing | -- | -- | -113.46% | 1,717.38% | -94.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 291.45% | 71.26% | -217.63% | 322.18% | -156.02% |